Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M. Sue O'dorisio. (1988) Neuropeptide Modulation of the Immune Response in Gut Associated Lymphoid Tissue. International Journal of Neuroscience 38:1-2, pages 189-198.
Read now
Read now
Articles from other publishers (34)
Argyrios Periferakis, Georgios Tsigas, Aristodemos-Theodoros Periferakis, Ioana Anca Badarau, Andreea-Elena Scheau, Mircea Tampa, Simona Roxana Georgescu, Andreea Cristiana Didilescu, Cristian Scheau & Constantin Caruntu. (2021) Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma. Analytical Cellular Pathology 2021, pages 1-13.
Crossref
Crossref
Aldona Kasprzak. (2021) Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 9:11, pages 1743.
Crossref
Crossref
Haruka Sekiya, Naho Yokota, Shota Takemi, Keiji Nakayama, Hiroki Okada, Takafumi Sakai & Ichiro Sakata. (2020) The inhibitory effect of somatostatin on gastric motility in <i>Suncus murinus</i>. Journal of Smooth Muscle Research 56:0, pages 69-81.
Crossref
Crossref
Chen Min, He Min, Peng Kemei, Xiao Ke, Huang Haibo, Zhu Daiyun & Zheng Xinting. (2014) Expression of somatostatin and cDNA cloning in the thymus of the African ostrich. Acta Histochemica 116:1, pages 191-196.
Crossref
Crossref
Brigid E. Gregg, Patrick C. Moore, Damien Demozay, Ben A. Hall, Mei Li, Aliya Husain, Amy J. Wright, Mark A. Atkinson & Christopher J. Rhodes. (2012) Formation of a Human β-Cell Population within Pancreatic Islets Is Set Early in Life. The Journal of Clinical Endocrinology & Metabolism 97:9, pages 3197-3206.
Crossref
Crossref
Raul M. Luque, Seungjoon Park & Rhonda D. Kineman. (2008) Role of endogenous somatostatin in regulating GH output under basal conditions and in response to metabolic extremes. Molecular and Cellular Endocrinology 286:1-2, pages 155-168.
Crossref
Crossref
George Marakis, Konstantinos Ballas, Savas Rafailidis, Michael Alatsakis, Kalliopi Patsiaoura & Athanassios Sakadamis. (2005) Somatostatin-producing pancreatic endocrine carcinoma presented as relapsing cholangitis — A case report. Pancreatology 5:2-3, pages 295-299.
Crossref
Crossref
Nan Jiang, Hidemasa Furue, Toshihiko Katafuchi & Megumu Yoshimura. (2003) Somatostatin directly inhibits substantia gelatinosa neurons in adult rat spinal dorsal horn in vitro. Neuroscience Research 47:1, pages 97-107.
Crossref
Crossref
Y Saavedra & P Vergara. (2003) Somatostatin inhibits intestinal mucosal mast cell degranulation in normal conditions and during mast cell hyperplasia. Regulatory Peptides 111:1-3, pages 67-75.
Crossref
Crossref
Shyama Chatterjee, Joris De Man & Eric Van Marck. (2001) Somatostatin and intestinal schistosomiasis: therapeutic and neuropathological implications in host–parasite interactions. Tropical Medicine & International Health 6:12, pages 1008-1015.
Crossref
Crossref
Diego Ferone, Rosario Pivonello, P. Martin Van Hagen, Marlijn Waaijers, Joke Zuijderwijk, Annamaria Colao, Gaetano Lombardi, Ad J. J. C. Bogers, Steven W. J. Lamberts & Leo J. Hofland. (2000) Age-related decrease of somatostatin receptor number in the normal human thymus. American Journal of Physiology-Endocrinology and Metabolism 279:4, pages E791-E798.
Crossref
Crossref
Sayuri Tanaka, Shigetaka Yamasaki, Hiroshi Matsushita, Yasunori Ozawa, Atsuko Kurosaki, Kazuo Takeuchi, Yoshio Hoshihara, Takehiko Doi, Gorou Watanabe & Katsuhiko Kawaminami. (2000) Duodenal somatostatinoma: A case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathology International 50:2, pages 146-152.
Crossref
Crossref
Carl Denef. 2011. Comprehensive Physiology. Comprehensive Physiology
461
514
.
G Peluso, O Petillo, M.A.B Melone, G Mazzarella, M Ranieri & G.F Tajana. (1996) Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides 30:5, pages 443-451.
Crossref
Crossref
Peter W. T. Pisters & Murray F. BrennanDavid L. Bartlett. 1996. Protein and Amino Acid Metabolism in Cancer Cachexia. Protein and Amino Acid Metabolism in Cancer Cachexia
213
225
.
Marco Matucci‐Cerinic, Francesco Borrelli, Sergio Generini, Alfredo Cantelmo, Isabella Marcucci, Fabrizio Martelli, Paolo Romagnoli, Stefano Bacci, Angelo Conz, Paolo Marinelli & Simone Marabini. (2005) Somatostatin‐induced modulation of inflammation in experimental arthritis. Arthritis & Rheumatism 38:11, pages 1687-1693.
Crossref
Crossref
David A. Walsh, Giorgio Terenghi & Julia M. Polak. (2006) Neural and vascular regulatory factors of the skin. Journal of the European Academy of Dermatology and Venereology 3:2, pages 116-139.
Crossref
Crossref
Marco Matucci-Cerinic. (1993) SENSORY NEUROPEPTIDES AND RHEUMATIC DISEASES. Rheumatic Disease Clinics of North America 19:4, pages 975-991.
Crossref
Crossref
D.J. EEDY. (1993) Neuropeptides in skin. British Journal of Dermatology 128:6, pages 597-605.
Crossref
Crossref
Sergei A. Grando. (1993) Physiology of endocrine skin interrelations. Journal of the American Academy of Dermatology 28:6, pages 981-992.
Crossref
Crossref
Juhani Sand, Hanna Tainio & Isto Nordback. (1993) Neuropeptides in pig sphincter of Oddi, bile duct, gallbladder, and duodenum. Digestive Diseases and Sciences 38:4, pages 694-700.
Crossref
Crossref
V. Chapman & A.H. Dickenson. (1992) The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord. Neuropeptides 23:3, pages 147-152.
Crossref
Crossref
Stephanie Rens‐Domiano & Terry Reisine. (2006) Biochemical and Functional Properties of Somatostatin Receptors. Journal of Neurochemistry 58:6, pages 1987-1996.
Crossref
Crossref
P. Pederzoli, M. Falconi, C. Bassi, L. Benetti & G. F. Briani. 1992. Pancreatic Fistulas. Pancreatic Fistulas
146
154
.
A. K. BURROUGHS & P. A. McCORMICK. (2007) Somatostatin and octreotide in gastroenterology. Alimentary Pharmacology & Therapeutics 5:4, pages 331-341.
Crossref
Crossref
J. Van Dam & M. M. Wolfe. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
55
88
.
Daniel R. Ciocca, Libertad A. Puy, Liliana C. Fasoli, Olga Tello, Juan C. Aznar, Francisco E. Gago, Sara I. Papa & Roberto Sonego. (1990) Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Research and Treatment 15:3, pages 175-184.
Crossref
Crossref
Paul N. Maton. (1989) The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors. Gastroenterology Clinics of North America 18:4, pages 897-922.
Crossref
Crossref
G. Williams & S.R. Bloom. (2009) Regulatory peptides, the hypothalamus and diabetes. Diabetic Medicine 6:6, pages 472-485.
Crossref
Crossref
Theodore S. Grabow, Dorothee M. Gaumann & Tony L. Yaksh. (1989) Electroencephalographic and behavioral assessment of intracerebroventricular somatostatin and a substance P analogue. Brain Research 489:2, pages 223-230.
Crossref
Crossref
G.S. Taylor & R.A.R. Bywater. (1989) Novel autonomic neurotransmitters and intestinal function. Pharmacology & Therapeutics 40:3, pages 401-438.
Crossref
Crossref
Janet A. Amico, Frances M. Finn & Jaya Haldar. (1988) Oxytocin and Vasopressin are Present in Human and Rat Pancreas. The American Journal of the Medical Sciences 296:5, pages 303-307.
Crossref
Crossref
B. Wiedenmann, U. Räth, R. Rädsch, F. Becker & B. Kommerell. (1988) Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201–995. Klinische Wochenschrift 66:2, pages 75-77.
Crossref
Crossref
S R Bloom & J M Polak. (1987) Somatostatin.. BMJ 295:6593, pages 288-290.
Crossref
Crossref